Cubist Systematic Strategies, LLC Cardiol Therapeutics Inc. Transaction History
Cubist Systematic Strategies, LLC
- $19.3 Billion
- Q3 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 25,079 shares of CRDL stock, worth $25,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,079Holding current value
$25,580% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
52Shares Held
7.39MCall Options Held
25KPut Options Held
0-
Tejara Capital LTD London, X02.63MShares$2.68 Million1.47% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD557KShares$568,5350.11% of portfolio
-
Bank Of America Corp Charlotte, NC551KShares$562,0740.0% of portfolio
-
Marshall Wace, LLP London, X0544KShares$555,2030.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il463KShares$472,7310.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $63.2M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...